Jump to main content

博士論文

Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma after Discontinuing Pembrolizumab as a Second-Line Treatment: A Retrospective Multicenter Real-World Cohort Study

Icons representing 博士論文
The cover of this title could differ from library to library.

Available in National Diet Library

Find on the publisher's website

NDL Digital Collections

Digital data available

Check on the publisher's website

Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma after Discontinuing Pembrolizumab as a Second-Line Treatment: A Retrospective Multicenter Real-World Cohort Study

Persistent ID (NDL)
info:ndljp/pid/14445991
Material type
博士論文
Author
山田, 豊博
Publisher
-
Date granted
2025-03-25
Material Format
Digital
Capacity, size, etc.
-
Degree grantor and degree
岐阜大学(Gifu University),博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Notes on use

Note (General)：

出版タイプ： VoR博士論文 (Doctoral dissertation)以下に掲載 Biomedicines (2022) 10(9), 2243

Search by Bookstore

Search by Bookstore

Read this material in an accessible format.

View materials in accessible formats for people with print disabilities (1Type)

Search by Bookstore

Read in Disability Resources

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Title
Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma after Discontinuing Pembrolizumab as a Second-Line Treatment: A Retrospective Multicenter Real-World Cohort Study
Author/Editor
山田, 豊博
Author Heading
山田, 豊博
Publication Date
2025-03-25
Publication Date (W3CDTF)
2025-03-25
Alternative Title
転移性尿路上皮癌患者における２次治療としてのペムブロリズマブ中止後の腫瘍学的転帰：後方視的多施設臨床コホート研究
Degree Grantor
岐阜大学(Gifu University)
Date Granted
2025-03-25
Date Granted (W3CDTF)
2025-03-25